AlphaGenRx

Collection

Metabolic Research

Metabolic-precision protocols engineered for sustainable body recomposition.

7 ProductsThird-Party Verified
TIRZ
GLP-1 / GIPMost Popular
TIRZ

TIRZ investigational reference material.

  • Research Mechanism — Investigates dual GIP and GLP-1 receptor activation to model incretin signaling, glucose regulation, appetite pathways, and body-composition changes in preclinical work. Cagrilintide is a frequent comparator arm in amylin-plus-incretin protocols.
  • Investigational Profile — Published research has expanded rapidly since the late 2010s, focused on receptor selectivity, energy balance, and lipid handling. It sits at the centre of the current dual-agonist incretin literature.
  • Research Study Window — Weekly-cadence laboratory arms are typically observed across eight- to sixteen-week windows so sustained receptor engagement and downstream metabolic endpoints have time to stabilise.
  • Pairs With — Cagrilintide

Regular

$149.99

Select Dosage→
Elite Member $134.99
Semaglutide
GLP-1Most Popular
Semaglutide

Semaglutide investigational reference material.

  • Research Mechanism — A GLP-1 receptor agonist analog investigated for post-prandial glucose kinetics, incretin-mediated satiety signaling, and gastric-emptying rates in metabolic models.
  • Investigational Profile — Peer-reviewed characterization has accumulated since the mid-2010s across glycemic-regulation, cardiometabolic, and appetite-pathway studies, forming the reference incretin against which newer dual and triple agonists are compared.
  • Research Study Window — Weekly-dosing kinetics keep most laboratory arms in the four- to twelve-week range so steady-state receptor engagement and satiety endpoints can be documented under consistent conditions.

Regular

$119.99

Select Dosage→
Elite Member $107.99
GLP-3(RT)
Triple AgonistMost Popular
GLP-3(RT)

GLP-3(RT) investigational reference material.

  • Research Mechanism — A triple agonist targeting GLP-1, GIP, and glucagon receptors, studied to model simultaneous incretin and energy-expenditure signaling. Direct comparison with TIRZ and Semaglutide is standard in the multi-receptor literature.
  • Investigational Profile — Peer-reviewed data on this class emerged in the early 2020s and remains one of the most actively investigated triple-agonist scaffolds in preclinical metabolism research.
  • Research Study Window — Study designs commonly observe response across four- to eight-week windows so glucagon-driven lipolytic activity and incretin-driven satiety endpoints can separate cleanly under controlled research conditions.

Regular

$159.99

Select Dosage→
Elite Member $143.99
Cagrilintide
Amylin Analog
Cagrilintide

Cagrilintide investigational reference material.

  • Research Mechanism — A long-acting amylin analog investigated for calcitonin- and amylin-receptor engagement, satiety signaling, and gastric-emptying modulation. Paired research with TIRZ or Semaglutide is common when amylin plus incretin activity is the question.
  • Investigational Profile — Amylin pharmacology has been in the literature since the 1980s, with long-acting analog work published from the late 2010s onward.
  • Research Study Window — Long-acting kinetics push observation windows into the six- to twelve-week range, giving amylin-specific satiety and gastric-emptying endpoints time to resolve.
  • Pairs With — Tirzepatide

Regular

$149.99

Select Dosage→
Elite Member $134.99
AOD-9604
Lipolytic Fragment
AOD-9604

AOD-9604 investigational reference material.

  • Research Mechanism — A modified fragment of the C-terminus of human growth hormone (residues 176–191) investigated for lipolytic pathway activity independent of full-length GH signaling.
  • Investigational Profile — Fragment research on this sequence has appeared in the adipose-metabolism literature since the 1990s and is a standard reference in fragment-versus-holohormone comparisons.
  • Research Study Window — Adipocyte and lipolysis endpoints are usually captured across two- to six-week laboratory observation periods in preclinical protocols.
  • Pairs With — MOTS-c

Regular

$99.99

Elite Member $89.99
5-Amino-1MQ
NNMT Inhibitor
5-Amino-1MQ

5-Amino-1MQ investigational reference material.

  • Research Mechanism — A small-molecule NNMT inhibitor investigated for its effect on cellular methylation balance, adipocyte metabolism, and NAD+ salvage flux. Often studied alongside NAD+ precursors when methyl-donor economy is the endpoint.
  • Investigational Profile — NNMT-inhibitor characterization built up steadily through the 2010s as the enzyme's role in adipose and hepatic methylation became better defined.
  • Research Study Window — Short cellular and preclinical protocols typically run over two- to four-week windows, tracking methylation and NAD+ pool changes over the observation period.

Regular

$94.99

Elite Member $85.49
SLU-PP-332
Exercise Mimetic
SLU-PP-332

SLU-PP-332 investigational reference material.

  • Research Mechanism — A small-molecule pan-ERR (estrogen-related receptor) agonist investigated for mitochondrial biogenesis, oxidative metabolism, and exercise-mimetic transcriptional programs.
  • Investigational Profile — Original characterization was published in 2023 and it has moved quickly into exercise-mimetic and metabolic-endurance research protocols.
  • Research Study Window — Mitochondrial and oxidative-capacity endpoints require multi-week observation, most commonly two to eight weeks depending on tissue and transcriptional readout.

Regular

$109.99

Elite Member $98.99

Third-Party Tested

Janoshik · ISO 17025

Cold-Chain Shipping

Insulated · Tracked

USA / Canada Made

Pharmaceutical Grade

Concierge Support

Clinician-Backed